This article is part of the supplement: Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008
Meeting abstract
Update on chronic immune thrombocytopenic purpura (ITP)
-
Correspondence: Robert McMillan robtmcmillan@sbcglobal.net
The Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA
Journal of Hematology & Oncology 2009, 2(Suppl 1):A5 doi:10.1186/1756-8722-2-S1-A5
Published: 26 June 2009First paragraph (this article has no abstract)
Chronic ITP is an autoimmune disorder manifested by immune-mediated platelet destruction and suppressed platelet production. The following article will discuss: normal platelet production and circulation; ITP pathophysiology; and diagnosis and treatment options for ITP.